Arun Richard Chandrasekaran

Title: Innovator Spotlight: Arun Richard Chandrasekaran

Introduction: Arun Richard Chandrasekaran, based in Albany, NY, has made notable contributions to the field of molecular diagnostics through his innovative work on nucleic acid-based nanoswitches. His groundbreaking research has the potential to significantly enhance analyte detection methods, offering advancements in diagnostic techniques.

Latest Patents: Arun holds a patent titled "Compositions and Methods for Analyte Detection Using Nanoswitches." This patent details a novel approach utilizing nucleic acid-based nanoswitches designed to detect specific nucleic acids and other types of analytes. One of the key features of this invention is its ability to induce a conformational change in the nanoswitches upon target binding, transitioning from a linear open conformation to a looped closed conformation. This advancement supports the creation of diagnostic assays capable of detecting, measuring, and purifying a variety of targets, including those present in low abundance, through simple gel electrophoresis readouts.

Career Highlights: Arun Richard Chandrasekaran has worked with notable institutions, including the Research Foundation for the State University of New York and the Children's Medical Center Corporation. His work in these organizations has allowed him to explore innovative solutions and contribute to advancing scientific research and applications.

Collaborations: Throughout his career, Arun has collaborated with esteemed colleagues such as Clinton H. Hansen and Mounir Ahmad Koussa. These partnerships have further enriched his research endeavors, fostering an environment of collaboration that often leads to increased innovation and discovery.

Conclusion: Arun Richard Chandrasekaran exemplifies the role of a dedicated inventor, pushing the boundaries of innovation in the field of diagnostics. With his patented technology and collaborative spirit, he continues to pave the way for enhanced methods of analyte detection, ultimately impacting healthcare and research positively.